Glocalink

Glocalink is a Tokyo-based venture firm that supports science and technology entrepreneurs with seed funding and hands-on assistance to commercialize laboratory technologies. Founded in 2010, the firm concentrates on technology companies, helping founders overcome technical and market hurdles through guidance and resources drawn from experience in bringing academic research to market.

Yoshinobu Osaka

President and CEO

Past deals in Tokyo

Japan Healthcare

Funding Round in 2019
Japan Healthcare Co., Ltd., established in 2017 and headquartered in Tokyo, specializes in the prevention of musculoskeletal diseases. It develops eco-friendly preventive medicines and offers innovative solutions such as Mirror Walk, a 3D walking analysis and guidance system, HOCO insoles for custom-made orthotics, and health management support services. The company aims to empower patients to lead pain-free lives through proactive health management.

CellFiber

Venture Round in 2017
CellFiber Co., Ltd., established in 2015 and headquartered in Tokyo, Japan, specializes in the development and sale of cell-laden soft materials. The company focuses on creating plug-and-play bio-manufacturing solutions using its proprietary CellFiberâ„¢ technology. This technology is designed to enhance yields and product quality, ensuring stability, predictability, reproducibility, and scalability for cell and gene therapy applications. By providing efficient cell mass production processes, CellFiber supports a wide range of applications from research to clinical use, ultimately lowering costs and development timelines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.